151 related articles for article (PubMed ID: 26371373)
1. Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia.
Inagaki J; Noguchi M; Kurauchi K; Tanioka S; Fukano R; Okamura J
Biol Blood Marrow Transplant; 2016 Feb; 22(2):300-306. PubMed ID: 26371373
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors Associated with Survival Following Ganciclovir Prophylaxis through Day +100 in Cytomegalovirus At-Risk Pediatric Allogeneic Stem Cell Transplantation Recipients: Development of Cytomegalovirus Viremia Associated with Significantly Decreased 1-Year Survival.
Klejmont LM; Mo X; Milner J; Harrison L; Morris E; van de Ven C; Cairo MS
Transplant Cell Ther; 2024 Jan; 30(1):103.e1-103.e8. PubMed ID: 37806447
[TBL] [Abstract][Full Text] [Related]
3. Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation.
Zhou JR; Shi DY; Wei R; Wang Y; Yan CH; Zhang XH; Xu LP; Liu KY; Huang XJ; Sun YQ
Front Immunol; 2020; 11():620891. PubMed ID: 33664733
[TBL] [Abstract][Full Text] [Related]
4. [Clinical Study of Allogeneic Hematopoietic Stem Cell Transplantation Patients with Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus].
Wang ZW; Liu Q; Sun HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):561-567. PubMed ID: 38660867
[TBL] [Abstract][Full Text] [Related]
5. Impact of Early Cytomegalovirus Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation on Relapse in Patients With Myelodysplastic Syndrome: A Nationwide Retrospective Study From Adult Myelodysplastic Syndrome Working Group of the JSTCT.
Konishi T; Matsuda K; Itonaga H; Doki N; Nishida T; Matsuoka KI; Ikeda T; Kanda Y; Fukuda T; Kanda J; Nakamae H; Imada K; Ueda Y; Ichinohe T; Atsuta Y; Ishiyama K
Transplant Cell Ther; 2024 Apr; ():. PubMed ID: 38697293
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: Experience from a Country with High Seropositivity.
Iftikhar R; Farhan M; Khan M; Chaudhry QUN; Ghafoor T; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Majeed A
Transplant Cell Ther; 2023 Aug; 29(8):521.e1-521.e7. PubMed ID: 37164292
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis.
Marty FM; Bryar J; Browne SK; Schwarzberg T; Ho VT; Bassett IV; Koreth J; Alyea EP; Soiffer RJ; Cutler CS; Antin JH; Baden LR
Blood; 2007 Jul; 110(2):490-500. PubMed ID: 17392502
[TBL] [Abstract][Full Text] [Related]
8. Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.
Borchers S; Bremm M; Lehrnbecher T; Dammann E; Pabst B; Wölk B; Esser R; Yildiz M; Eder M; Stadler M; Bader P; Martin H; Jarisch A; Schneider G; Klingebiel T; Ganser A; Weissinger EM; Koehl U
PLoS One; 2012; 7(12):e50248. PubMed ID: 23272059
[TBL] [Abstract][Full Text] [Related]
9. Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.
Seo E; Choi ES; Kim JH; Kim H; Koh KN; Im HJ; Lee J
PLoS One; 2021; 16(2):e0246191. PubMed ID: 33544726
[TBL] [Abstract][Full Text] [Related]
10. CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia.
Akahoshi Y; Nakasone H; Takenaka K; Yamasaki S; Nakamura M; Doki N; Tanaka M; Ozawa Y; Uchida N; Ara T; Nakamae H; Ota S; Onizuka M; Yano S; Tanaka J; Fukuda T; Kanda Y; Atsuta Y; Kako S; Yanada M; Arai Y
Blood Adv; 2023 Jun; 7(12):2699-2708. PubMed ID: 36661335
[TBL] [Abstract][Full Text] [Related]
11. Donor aKIR genes influence the risk of EBV and CMV reactivation after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation.
Gao F; Shi Z; Shi J; Luo Y; Yu J; Fu H; Lai X; Liu L; Yuan Z; Zheng Z; Huang H; Zhao Y
HLA; 2024 Jan; 103(1):e15320. PubMed ID: 38081622
[TBL] [Abstract][Full Text] [Related]
12. Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?
Rostami T; Rostami MR; Mirhosseini AH; Mohammadi S; Nikbakht M; Alemi H; Khavandgar N; Rad S; Janbabai G; Mousavi SA; Kiumarsi A; Kasaeian A
Stem Cell Res Ther; 2024 Apr; 15(1):111. PubMed ID: 38644499
[TBL] [Abstract][Full Text] [Related]
13. The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping.
Wu X; Ma X; Song T; Liu J; Sun Y; Wu D
Ann Hematol; 2024 Mar; 103(3):917-933. PubMed ID: 38227006
[TBL] [Abstract][Full Text] [Related]
14. CMV infection is a risk factor for hemorrhagic cystitis after hematopoietic stem cell transplantation.
Zhang L; Khadka B; Wu J; Feng Y; Long B; Xiao R; Liu J
Ann Hematol; 2023 May; 102(5):1193-1201. PubMed ID: 36752843
[TBL] [Abstract][Full Text] [Related]
15. Application of CMV-IVIg as prophylaxis against cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation patients.
Cui J; Zhou Y; Zhao K; Li X; Zhang H; Zhang X; Sun Y; Long B
Clin Transplant; 2024 Apr; 38(4):e15300. PubMed ID: 38555576
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation.
Hu J; Zhao J; Wang C; Jia M; Su M; Li S
Ann Hematol; 2023 Dec; 102(12):3593-3601. PubMed ID: 37831153
[TBL] [Abstract][Full Text] [Related]
17. The effect of varicella-zoster virus reactivation on the long-term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantation.
Li P; Li J; Huang H; Chen X; Lin Y; He G; Xu D
J Health Popul Nutr; 2023 Oct; 42(1):105. PubMed ID: 37784192
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of 34 patients with cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation].
Li S; Shen ZH; Wan LP; Bao AH; Yang J; Tong Y; Wang C
Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):843-847. PubMed ID: 33190442
[No Abstract] [Full Text] [Related]
19. Impact of Early Natural Killer Cell Reconstitution on the Outcomes of T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation.
Zhou Z; Liu X; Zhang X; Wen S; Hua H; Wang Z; Xu Z; Lu Y; Wang F
J Inflamm Res; 2023; 16():2993-3008. PubMed ID: 37489148
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.
Casto AM; Seo S; Levine DM; Storer BE; Dong X; Hansen JA; Boeckh M; Martin PJ
Blood; 2021 Oct; 138(17):1628-1636. PubMed ID: 34269803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
